Delivery Order SPE2DB24D1104-SPE2DB25FXWC2
Award Date
12/31/24
Potential Completion Date
1/2/25
Potential Value
$19K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. The contract, valued at $1,165.46, is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in units of 30.
The award is a delivery order under a broader Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order, valued at $6,285.77, is for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in bottles of 30 to support military healthcare programs. The contract has a firm fixed price and an ultimate completion date of November 12, 2024.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,017.19 firm-fixed-price delivery order is for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit doses of 30s. The contract has an ultimate completion date of October 29, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This federal contract award, valued at $10,775.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging, with a completion date of December 10, 2024. This award is not associated with a set-aside program and represents a firm fixed-price delivery order. Amerisourcebergen Drug Corp, a for-profit...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,844.08 firm fixed-price delivery order is for the supply of Telmisartan-HCTZ 80-25 mg tablets in 30-count packages. This contract has no set-aside designation, indicating open competition.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets. The Firm Fixed Price delivery order, valued at $56,821.15, has a period of performance through November 5, 2024. This award is not designated as a set-aside contract.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as well as a...
This federal contract award, valued at $61,689.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in unit doses of 30s. This is a firm-fixed-price delivery order contract, with a completion date of December 28, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, valued at $26,564.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count units. The award does not have a set-aside designation, indicating open competition.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,401.79, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Telmisartan-Amlodipine 40-5 mg tablets, a cardiovascular medication, with a completion date of December 18, 2024.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,871.62, is a Delivery Order with a Firm Fixed Price pricing type. The purpose is to provide Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging of 30's. This award is not associated with a set-aside designation, indicating open competition.
Amerisourcebergen holds a...